Safety and Efficacy of Enfortumab Vedotin in a Patient With Metastatic Urothelial Carcinoma on Dialysis: A Case Report.
Yuto Tsubonuma; Yujiro Nagata; Katsuyoshi Higashijima; Akinori Minato; Ikko Tomisaki; Naohiro Fujimoto
Cureus, Jan. 2025, Reviewed, No invitation
Lead

重症腎感染症に伴う感染性肺塞栓症の1例
坪沼 裕人, 室岡 和樹, 生田 弘文, 濱砂 良一, 添田 博康, 岩崎 健
西日本泌尿器科, Oct. 2023, Reviewed, No invitation
Lead

Second-Line Systemic Therapy for Highly Aggressive Neuroendocrine Prostate Cancer.
Fujimoto Naohiro, Tsubonuma Yuto, Nagata Yujiro, Minato Akinori, Tomisaki Ikko, Harada Kenichi, Miyamoto Hiroshi
Anticancer research, Sep. 2023, Reviewed, No invitation

Safety and Efficacy of Enfortumab Vedotin in a Patient With Metastatic Urothelial Carcinoma on Dialysis: A Case Report.
Tsubonuma Yuto, Nagata Yujiro, Higashijima Katsuyoshi, Minato Akinori, Tomisaki Ikko, Fujimoto Naohiro
Cureus, Jan. 2025, Reviewed, No invitation
Lead

Treatment Outcomes of Second-Line Systemic Therapy for Neuroendocrine Prostate Cancer: A Report of Four Cases.
Tsubonuma Yuto, Funakoshi Keita, Takaba Tomohisa, Jyojima Kazumasa, Minato Akinori, Tomisaki Ikko, Harada Kenichi, Fujimoto Naohiro
Journal of UOEH, 2024, Reviewed, No invitation
Lead